文献速递神经肿瘤

不同种族和族裔人群中脑膜瘤基因组谱与临床行为的差异

Variations in the genomic profiles and clinical behavior of meningioma by racial and ethnic group.
PubMed 文献 · J Neurosurg · 2024-03-22

该研究分析了2008年9月至2021年11月接受手术的460例散发性颅内脑膜瘤患者,比较不同种族/族裔的基因组与临床差异。黑人患者前颅底肿瘤和体细胞hedgehog突变率更高,复发率更高且无进展生存期更短;西班牙裔患者更年轻、症状更多、TRAF7突变率更高,但1p缺失较少且无进展生存期无差异。

要点

  • 黑人患者前颅底肿瘤OR 3.2(95%CI 1.7-6.3,p=0.0008),体细胞hedgehog突变OR 5.3(95%CI 1.6-16.6,p=0.003)。
  • 黑人患者复发OR 2.6(95%CI 1.3-5.2,p=0.009),无进展生存期HR 2.9(95%CI 1.6-5.4,p=0.002),切除程度与非黑人相似(p=0.745)。
  • 西班牙裔患者手术年龄更年轻(53.9 vs 60.2岁,p=0.0006),TRAF7突变OR 2.96(95%CI 1.1-7.8,p=0.036)。

核心结论

  • 尽管切除程度相似,黑人患者脑膜瘤切除后临床结局更差,表现为体细胞hedgehog突变患病率更高、复发率更高和无进展生存期更短。
  • 西班牙裔患者脑膜瘤侵袭性较低,有TRAF7突变倾向,无进展生存期无差异。
  • 这些发现可为脑膜瘤的照护和治疗策略提供信息,并为未来聚焦这些差异的基因组起源的研究奠定基础。

研究设计与样本

  • 分析2008年9月至2021年11月期间接受手术的18岁及以上散发性脑膜瘤患者的人口学、基因组和临床数据。
  • 进行统计分析以检测所有种族/族裔组间的差异,并直接比较黑人与非黑人组以及西班牙裔与非西班牙裔组。
  • 研究纳入460例颅内脑膜瘤患者。

主要发现

  • 西班牙裔患者手术时显著更年轻(53.9 vs 60.2岁,p=0.0006),且更可能出现症状。
  • 黑人患者前颅底肿瘤发生率更高(OR 3.2,95%CI 1.7-6.3,p=0.0008),体细胞hedgehog突变率更高(OR 5.3,95%CI 1.6-16.6,p=0.003)。
  • 西班牙裔患者较少呈现染色体1p缺失这一侵袭性基因组特征(OR 0.28,95%CI 0.07-1.2,p=0.06),TRAF7体细胞驱动突变率更高(OR 2.96,95%CI 1.1-7.8,p=0.036)。
  • 黑人患者复发率更高(OR 2.6,95%CI 1.3-5.2,p=0.009),无进展生存期更短(HR 2.9,95%CI 1.6-5.4,p=0.002),尽管切除程度与非黑人患者相似(p=0.745)。
  • 各组间总生存期未观察到显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The influence of socioeconomic factors on racial disparities among patients with sporadic meningiomas is well established, yet other potential causative factors warrant further exploration. The authors of this study aimed to determine whether there is significant variation in the genomic profile of meningiomas among patients of different races and ethnicities and its correlation with clinical outcomes. METHODS: The demographic, genomic, and clinical data of patients aged 18 years and older who had undergone surgery for sporadic meningioma between September 2008 and November 2021 were analyzed. Statistical analyses were performed to detect differences across all racial/ethnic groups, as were direct comparisons between Black and non-Black groups plus Hispanic and non-Hispanic groups. RESULTS: This study included 460 patients with intracranial meningioma. Hispanic patients were significantly younger at surgery (53.9 vs 60.2 years, p = 0.0006) and more likely to show symptoms. Black patients had a higher incidence of anterior skull base tumors (OR 3.2, 95% CI 1.7-6.3, p = 0.0008) and somatic hedgehog mutations (OR 5.3, 95% CI 1.6-16.6, p = 0.003). Hispanics were less likely to exhibit the aggressive genomic characteristic of chromosome 1p deletion (OR 0.28, 95% CI 0.07-1.2, p = 0.06) and displayed higher rates of TRAF7 somatic driver mutations (OR 2.96 95% CI 1.1-7.8, p = 0.036). Black patients had higher rates of recurrence (OR 2.6, 95% CI 1.3-5.2, p = 0.009) and shorter progression-free survival (PFS; HR 2.9, 95% CI 1.6-5.4, p = 0.002) despite extents of resection (EORs) similar to those of non-Black patients (p = 0.745). No significant differences in overall survival were observed among groups. CONCLUSIONS: Despite similar EORs, Black patients had worse clinical outcomes following meningioma resection, characterized by a higher prevalence of somatic hedgehog mutations, increased recurrence rates, and shorter PFS. Meanwhile, Hispanic patients had less aggressive meningiomas, a predisposition for TRAF7 mutations, and no difference in PFS. These findings could inform the care and treatment strategies for meningiomas, and they establish the foundation for future studies focusing on the genomic origins of these observed differences.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Tabor JK, Dincer A, O'Brien J, et al. Variations in the genomic profiles and clinical behavior of meningioma by racial and ethnic group. J Neurosurg. 2024. PMID: 38518289. doi:10.3171/2024.1.JNS231633

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。